Literature DB >> 17721620

Tyrosine phosphorylation / dephosphorylation balance is involved in thrombin-evoked microtubular reorganisation in human platelets.

Aicha Bouaziz1, Nidhal Ben Amor, Geoffrey E Woodard, Hanen Zibidi, José J López, Ahgleb Bartegi, Ginés M Salido, Juan A Rosado.   

Abstract

We have investigated the intracellular mechanisms involved in microtubular remodelling by thrombin and its possible involvement in platelet aggregation and secretion. Platelet stimulation with thrombin induces a time- and concentration-dependent regulation of the microtubular content, which was found to be maximally effective at the concentration 0.1 U/ml. Thrombin (0.1 U/ml) evoked an initial decrease in the microtubule content detectable at 5 seconds (sec) and reached a minimum 10 sec after stimulation. The microtubular content then increased, exceeding basal levels again approximately 30 sec after stimulation. Inhibition of tyrosine phosphatases using vanadate abolished thrombin-induced microtubular depolymerisation while inhibition of tyrosine kinases by methyl-2,5-dihydroxycinnamate prevented microtubule polymerisation. Thrombin activates the cytosolic Bruton's tyrosine kinase (Btk) and Src proteins. Inhibition of Btk or Src by LFM-A13 or PP1, respectively, abolished thrombin-induced microtubular polymerisation, while maintaining intact its ability to induce initial depolymerisation. Microtubular disruption by colchicine significantly reduced thrombin-induced platelet aggregation and ATP secretion. Similar results were observed after inhibition of microtubular disassembly by paclitaxel. These findings indicate that thrombin induces microtubular remodelling by modifying the balance between protein tyrosine phosphorylation and dephosphorylation. The former seems to be required for microtubular polymerisation, while tyrosine dephosphorylation is required for microtubular depolymerisation. Both, initial microtubular disassembly and subsequent polymerisation are required for thrombin-induced platelet aggregation and secretion in human platelets.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17721620

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  6 in total

1.  Effect of Colchicine on Platelet-Platelet and Platelet-Leukocyte Interactions: a Pilot Study in Healthy Subjects.

Authors:  Binita Shah; Nicole Allen; Bhisham Harchandani; Michael Pillinger; Stuart Katz; Steven P Sedlis; Christina Echagarruga; Svetlana Krasnokutsky Samuels; Pajazit Morina; Prabhjot Singh; Liza Karotkin; Jeffrey S Berger
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

2.  Tyrosine kinase Btk is required for NK cell activation.

Authors:  Yan Bao; Jian Zheng; Chaofeng Han; Jing Jin; Huanxing Han; Yinping Liu; Yu-Lung Lau; Wenwei Tu; Xuetao Cao
Journal:  J Biol Chem       Date:  2012-05-15       Impact factor: 5.157

3.  Colchicine inhibits ROS generation in response to glycoprotein VI stimulation.

Authors:  G J Pennings; C J Reddel; M Traini; H Campbell; V Chen; L Kritharides
Journal:  Sci Rep       Date:  2021-06-07       Impact factor: 4.379

4.  Effect of homocysteine on calcium mobilization and platelet function in type 2 diabetes mellitus.

Authors:  N Alexandru; I Jardín; D Popov; M Simionescu; J García-Estañ; G M Salido; J A Rosado
Journal:  J Cell Mol Med       Date:  2008-10       Impact factor: 5.310

5.  Effect of homocysteine on calcium mobilization and platelet function in type 2 diabetes mellitus.

Authors:  N Alexandru; I Jardín; D Popov; M Simionescu; J García-Estañ; G M Salido; J A Rosado
Journal:  J Cell Mol Med       Date:  2008-12       Impact factor: 5.310

Review 6.  Exploratory Review of the Role of Statins, Colchicine, and Aspirin for the Prevention of Radiation-Associated Cardiovascular Disease and Mortality.

Authors:  Maria Isabel Camara Planek; Adam J Silver; Annabelle Santos Volgman; Tochukwu M Okwuosa
Journal:  J Am Heart Assoc       Date:  2020-01-21       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.